News and Analysis MediLink scores $70m Series B Drug developer MediLink has secured $70 million in Series B financing. Iris Dorbian - 14 March 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
